Tagged with M

France Frédéric Collet, president Novartis France and general manager oncology explains the rationale behind Novartis’s consistent investment in France, the current shift in the company’s corporate culture and the main challenges inherent to the unprecedented wave of innovation that is revolutionizing the health industry.   In terms of research, we have invested EUR…

Spain Javier Alvarado, general manager of Mundipharma Spain, discusses his current priorities and the innovation the company is bringing to the market through a diversified portfolio. Furthermore, he points out the importance of long-term strategic partnerships for the company´s success and his future aspirations for the affiliate.   Of course, none…

Korea The South Korean medical devices market has expanded significantly in recent years; from USD 4.2 billion in 2013 to USD 5.5 billion in 2017. Production, exports and imports are all on the rise too, as the below chart shows.  The Top 10 export and import destinations for Korean medtech. The…

Spain Yann Gaslain, CEO of Procare Health, a local player dedicated to innovative natural women’s health products, outlines his strategy to set up the company since 2012 and gives an overview of his company’s star product, Papilocare. Furthermore, he points out the company’s internationalisation and R&D strategy and highlights the importance…

Korea Shingyu Bae, CEO of MDimune, explains how the company’s new exosome drug delivery system increases efficacy and reduces toxicity compared with other oncology products. He also discusses the potential and attractiveness of the Korean biotech industry as a global leader in developing new technologies.   Our vision is to give…

Turkey Gamze Çıtıroğlu, Murat Çıtıroğlu and Pınar Çakır of Ekin Kimya discuss the progress of the Turkish pharma industry moving towards biotechnology. Moreover, they give insights into Ekin Kimya’s partnership strategy for pharmaceutical production, highlighting the importance of quality and customer-centricity.   Turkey’s pharma sector is growing rapidly and it comes…

Opinion Carla Smith is a healthcare thought leader with nearly 30 years’ experience. She champions transformational strategy, governance, and policy in the health sector, particularly in the areas of digital health and health IT. In this article, Ms Smith discusses the massive potential of digital therapeutics in helping patients manage their…

Malta Andrew Corrieri of Pharmaconsulta in Malta outlines his consultancy’s comprehensive service offering, the opportunities inherent in the Maltese life sciences industry and his plans for the future.   By overseeing the entire spectrum of regulatory affairs, we are able to act more efficiently and prevent any hiccups or delays that…

IFPMA Eli Lilly and Company’s Melissa Barnes, who chairs the Ethics and Business Integrity Committee (eBIC) at the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), and Thomas Cueni, the organisation’s director general, outline the key features of the IFPMA’s ambitious new Code of Practice and discuss the state of ethics…

Algeria Moncef Meklati, Merck’s general manager for North West Africa, discusses the company’s ambitions in the region, the key to successful joint ventures and evolving attitudes to chronic diseases in Algeria.   From the first day I started working for Merck, I’ve been impressed by the strong commitment of my team…

France Nicolas Bardonnet of Promega France discusses the standout growth of the company on the occasion of its 40th anniversary, collaboration with France’s biotech clusters and the growth drivers of the future.   In France, we start to see hospitals coming to us, but also clinical diagnostic laboratories because for a…

Spain Sergio Serra Ripol, managing director of Tillotts Pharma Spain, highlights the challenges associated with setting up the affiliate and the strategic importance of Spain as Tillotts grows its European footprint. Furthermore, he gives an insight into the importance of relationships in building the company’s network and his vision for the…